| Financial Year |
December 31 2020 |
| Monetary Funds |
1,479,471,102.38 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
141,653,362.66 |
| Advances to Suppliers |
74,744,473.76 |
| Other Receivables |
451,690,966.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
845,153,460.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,891,189.33 |
| Total Current Assets |
3,011,604,555.26 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,928,439.94 |
| Investment Properties |
-- |
| Fixed Assetes |
31,096,484.16 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,347,987.64 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,996,283.46 |
| Deferred Income Tax Assets |
33,619,406.36 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
103,509,661.08 |
| Total Assets |
3,115,114,216.34 |
| Short-Term Loans |
13,216,800.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
180,348,386.00 |
| Accounts Payable |
262,239,529.20 |
| Accounts Received In Advance |
111,733.40 |
| Employee Compensation Payable |
73,534,366.57 |
| Taxes Payable |
183,960,427.99 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
67,248,914.85 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
780,660,158.01 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
-- |
| Total Liabilities |
780,660,158.01 |
| Paid-In Capital(Or Share Stock) |
400,010,000.00 |
| Capital Surplus |
718,698,628.04 |
| Surplus Reserve |
63,994,561.92 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,157,176,860.69 |
| Minority Stockholder's Interest |
-4,578,161.13 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,339,032,219.46 |
| Owner's Equity（Stockholder's Equity） |
2,334,454,058.33 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,115,114,216.34 |
